Tuesday, 16 April 2019

FDA clears HemoSonics' rapid coagulation diagnostic for hospital transfusion management - FierceBiotech

FDA clears HemoSonics' rapid coagulation diagnostic for hospital transfusion management  FierceBiotech

The FDA has granted a de novo clearance to HemoSonics' point-of-care diagnostic for determining a patient's coagulation status within 15 minutes, to respond ...

No comments:

Post a Comment